PowerPoint Presentation

MARKET INTELLIGENCE . CONSULTING

www.techsciresearch.com

FY2017 – FY2027

INDIA RESPIRATORY INHALERS MARKET

FORECAST & OPPORTUNITIES

Scope of Report

Product of Interest (POI): Respiratory Inhalers

Review Period

FY2017 – FY2020

Base Year

FY2021

Estimated Year

FY2022

Forecast Period

FY2023 – FY2027

Year Range

An inhaler (also known as a puffer, pump or allergy spray) is a medical device used for delivering medicines into the lungs through the work of a person's breathing. This allows medicines to be delivered to and absorbed in the lungs, which provides the ability for targeted medical treatment to this specific region of the body, as well as a reduction in the side effects of oral medications. There are a wide variety of inhalers, and they are commonly used to treat numerous medical conditions with asthma and chronic obstructive pulmonary disease (COPD) being among the most notable.

Market Segmentation

REGION

North

East

West

South

PRODUCT TYPE

Dry Powder Inhaler

Metered Dose Inhaler

Others

DISTRIBUTION CHANNEL

Online

Offline

APPLICATION

Manually Operated Inhalers

Digitally Operated Inhalers

COPD

Asthma

Pulmonary Atrial Hypertension

Others

DISEASE INDICATION

‹#›

© TechSci Research

Note: These are dummy figures; please purchase our report for actual data

Table of Contents

S. No. ContentsPage No.1.Product Overview (A brief description of the category and product inclusions considered under the scope of the study to give clear picture to the client about the product of interest.)2. Research Methodology (A detailed methodology on how we have derived the market related information and what are the measures that has been taken to validate the data.)3.Impact of COVID-19 on India Respiratory Inhalers Market4.Executive Summary5.Voice of Customer6.India Respiratory Inhalers Market Outlook, FY2017-FY2027F (This chapter includes a brief overview of the product of interest market such as total market’s growth rate, expected growth rate, key growth levers, leading region, top grossing product types, etc. It includes more of a qualitative information about the market.)6.1.Market Size & Forecast(This chapter would include the market size i.e., the revenue generated from the India Respiratory Inhalers market in one year. In this case, the market size will be provided in value terms for historic period (FY2017-FY2020); current/base year (FY2021); estimated year (FY2022E); and forecast (FY2023-FY2027))6.1.1.By Value & Volume6.2.Market Share & Forecast (The overall product of interest bifurcated/split among various segments. )6.2.1.By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Others)6.2.2.By Technology (Manually Operated Inhalers v/s Digitally Operated Inhalers)6.2.3.By Disease Indication (COPD, Asthma, Pulmonary Atrial Hypertension, Others)6.2.4.By Distribution Channel (Online v/s Offline)6.2.5.By End User (Hospitals & Clinics, Homecare, Others)6.2.6.By Company (FY2021)6.2.7.By Region 6.3.Product Market Map

‹#›

S. No. ContentsPage No.7.India Manually Operated Inhalers Market Outlook, FY2017-FY2027F7.1.Market Size & Forecast7.1.1.By Value & Volume7.2.Market Share & Forecast7.2.1. By Product Type7.2.2. By Disease Indication7.2.3. By Distribution Channel7.2.4. By End User8.India Digitally Operated Inhalers Market Outlook, FY2017-FY2027F8.1.Market Size & Forecast8.1.1.By Value & Volume8.2.Market Share & Forecast8.2.1. By Product Type8.2.2. By Disease Indication8.2.3. By Distribution Channel8.2.4. By End User

Table of Contents

‹#›

S. No. ContentsPage No.9.Market Dynamics9.1.DriversDrivers9.2.ChallengesChallenges10.Market Trends & Developments11.Policy & Regulatory Landscape12.Import-Export Analysis13.Pricing Analysis14.India Economic Profile15.Competitive Landscape15.1.Competition Outlook15.2.Company Profiles15.2.1.Company Details15.2.2.Products & Services15.2.3. Financials (As Reported)15.2.4. Key Market Focus & Geographical Presence15.2.5. Recent Developments15.2.6. Key Management Personnel16.Strategic Recommendations (Based on the findings of the report strategic recommendations on how to enter and expand market share)17.About Us & Disclaimer

Table of Contents

‹#›

RESEARCH

METHODOLOGY

Research Methodology

Identifying Key Opinion Leaders

Questionnaire Design

In-depth Interviews

Data Collection

Developing List of Respondents

Formulating Questionnaire

Market Profiling

Data Validation

Data Analysis

In-depth secondary research was conducted to determine top players in India respiratory inhalers market, overall market size and segmental market size.

In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide.

List of industry players and industry specialists was developed.

TechSci conducted interviews with industry experts and industry players for data collection and verification.

Data obtained as a result of primary and secondary research was validated through rigorous triangulation.

The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about India respiratory inhalers market.

Data

Collection

Data Filter

& Analysis

Research &

Intelligence

Actionable

Insights

Business

Solution

Primary Research

Desk Research

Company Analysis

Recent Developments

Market Changing Aspects/Dynamics

Government Policies

Conclusion

Market Participants

Key Strengths

LinkedIn

TechSci Internal Database

Factiva

Hoovers

Paid Sources

Company Websites

Company Annual Reports

White Paper Study

Financial Reports

Investor Presentations

Regulatory Body

Associations, etc.

Secondary Research

Primary Research

‹#›

Research Methodology

Baseline Methodology

Our dedicated team of industry experts has monitored and analyzed various aspects of India respiratory inhalers market. The team has analyzed the outlook of various segments of this market, while considering the major influencing factors such as rising demand for respiratory inhalers. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in India respiratory inhalers market.

Methodology Followed for Calculation of Market Size:

Market Size by Value: Market size, in terms of value, for the year FY2021 was calculated based on information collected through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as respiratory inhalers companies, channel partners, end-user industry experts, and other industry participants.

The team interviewed more than 15-20 respiratory inhalers market companies, 100 – 120 end use industries, and 15 – 20 industry experts and other value chain stakeholders in India respiratory inhalers market to obtain the overall market size for FY2017-FY2021, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data for FY2017-FY2021.

Respondents were asked about the current and future market growth rates, market shares by product type, by technology, by disease indication, by distribution channel, by end user, by company and by region. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.

‹#›

8

Research Methodology

Methodology Followed for Calculation of Market Shares:

Market shares by product type, by technology, by disease indication, by distribution channel, by end user, by company and by region by product type, by modality, by application, by end user, by company and by region were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of respiratory inhalers market. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.

Methodology Followed for Forecasting:

TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.

Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast India respiratory inhalers market, TechSci Research used various forecast techniques such as:

Moving Average

Time Series Analysis

Regression Analysis

Econometric and Judgmental Analysis

‹#›

Research Methodology

TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market including market share data.

Partial List of Companies Interviewed Key Secondary TypesPhilips India LimitedCipla LimitedTeva API India LimitedAstra Zeneca Pharma India LimitedGlaxoSmithKline Pharmaceuticals LtdOmron Healthcare India Pvt. Ltd.Novartis India Ltd.3M India ltdGlenmark Pharmaceuticals LimitedMerck IndiaWorld BankTechSci Research Proprietary Database & Knowledge RepositoryCompany Annual Reports Industry MagazinesIndustry ReportsNews DailiesCredible Paid Databases

‹#›

Industry Brief

According to TechSci Research report, “India Respiratory Inhalers Market By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Others), By Technology (Manually Operated Inhalers v/s Digitally Operated Inhalers), By Disease Indication (COPD, Asthma, Pulmonary Atrial Hypertension, Others), By Distribution Channel (Online v/s Offline), By End User (Hospitals & Clinics, Homecare, Others), By Company, By Region, Forecast & Opportunities, FY2027”, India Respiratory Inhalers market is expected to witness steady growth for the next five years. Increasing incidences of respiratory diseases is a major disorder and need effective treatment. Asthma, COPD, and pulmonary diseases are the most common respiratory related diseases. To cure the prevailing respiratory diseases, the need for respiratory inhalers is on rise. Inhalers’ major advantage is that the drug directly travels into the respiratory system thereby is very effective in nature. They are majorly available as soft mist inhalers and breathing actuated inhalers. Each inhaler consists of metered dosage. Due to benefits and rising demand for inhalers, government is supporting the production of respiratory inhalers. Rise in initiatives by government authorities to provide affordable and accessible medication is driving the marker demand. Respiratory inhalers are provided at reasonable rates to patients. High-end investments by manufacturers to increase the product efficiency and increase the product awareness is increasing the product demand in the region. Increasing preference towards adoption of smoking and drinking habits due to increased expenditure capacity and to cope up with high-level of stress affects the respiratory system adversely and gives rise to a number of pulmonary diseases.

Due to the ongoing pandemic COVID-19, lockdown was imposed all over the country. Complete shutdown was observed, and people started practicing social distancing and avoided going out to avail healthcare facilities. Demand for respiratory inhalers, especially allergy and asthma curing respiratory inhalers is increasing at a rapid pace. Health professionals are advising patients to stay indoors as a precautionary measure. Consumers are preferring home medications which is accelerating the demand for respiratory inhalers. Rising awareness regarding respiratory diseases and increasing production of respiratory inhalers is expected to fuel the growth of the market till the forecast period. However, lack of knowledge about the usage of respiratory inhalers may hamper the market growth during the forecast period.

Based on technology, market is further bifurcated into manually operated inhalers and digitally operated inhalers. Manually operated inhalers are dominating the respiratory inhalers market for the forecast period as digital technology is still at developing stage. Primary aim for respiratory inhalers is to effectively deliver the drug for effective treatment of respiratory related illnesses. Advancements in technology to optimize the performance of respiratory illness such as increasing the precision of drug dosage, quick action of inhalers and systematic absorption inside the body is expected to boost the demand for respiratory inhalers. Based on disease indication, market is majorly divided into COPD, asthma, pulmonary atrial hypertension, and others. COPD segment is accounted to major market share in the predicted period due to high prevalence of disease in the region and the increasing deaths occurred due to people suffering from COPD. Increasing demand for effective treatment is aiding to high market growth. Government initiatives to promote quality healthcare services to patients and reimbursement plans is contributing to increasing demand for respiratory inhalers in the region.

Philips India Limited, Cipla Limited, Teva API India Limited, Astra Zeneca Pharma India Limited, GlaxoSmithKline Pharmaceuticals Ltd, Omron Healthcare India Pvt. Ltd., Novartis India Ltd., 3M India ltd, Glenmark Pharmaceuticals Limited, Merck India are the leading players operating in the India respiratory inhalers market. Manufacturers are increasingly focusing on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several respiratory inhalers manufacturers are coming up with their technologically advanced offerings.

“Adoption of latest technologies by inhalers manufacturing companies in form of smart inhalers which uses Bluetooth technology to gather the required information and remind patients to take medication at proper time. Smart inhalers are integrated with sensors and alerts when a patient enters a highly polluted or high pollen area. Smart inhalers can be digitally connected to laptops or smart devices and other benefits is expected to propel the demand for respiratory inhalers throughout the forecast period” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

‹#›

11

Sample Data - Snapshot

India Respiratory Inhalers Market Size, By Value (USD Million), & Volume (Million Tonnes), FY2017-FY2027F

CAGR By Value & Volume

XX%

CAGR By Value & Volume

YY%

India Respiratory Inhalers Market Share, By Distribution Channel, By Value, FY2017-FY2027F

India Manually Operated Inhalers Market Share, By Disease Indication, By Value, FY2017–FY2027F

‹#›

12

By Value (USD Million)

FY2017FY2021FY2022EFY2027F56789101112131415By Volume (Million Tonnes)

FY2017FY2021FY2022EFY2027F102030405060708090100110

Online 

FY2017FY2018FY2019FY2020FY2021FY2022EFY2023FFY2024FFY2025FFY2026FFY2027F0.50.50.50.50.50.50.50.50.50.50.5Offline

FY2017FY2018FY2019FY2020FY2021FY2022EFY2023FFY2024FFY2025FFY2026FFY2027F0.50.50.50.50.50.50.50.50.50.50.5

COPD

FY2017FY2018FY2019FY2020FY2021FY2022EFY2023FFY2024FFY2025FFY2026FFY2027F0.250.250.250.250.250.250.250.250.250.250.25Asthma

FY2017FY2018FY2019FY2020FY2021FY2022EFY2023FFY2024FFY2025FFY2026FFY2027F0.250.250.250.250.250.250.250.250.250.250.25Pulmonary Atrial Hypertension

FY2017FY2018FY2019FY2020FY2021FY2022EFY2023FFY2024FFY2025FFY2026FFY2027F0.250.250.250.250.250.250.250.250.250.250.25Others

FY2017FY2018FY2019FY2020FY2021FY2022EFY2023FFY2024FFY2025FFY2026FFY2027F0.250.250.250.250.250.250.250.250.250.250.25

Report Data

License Type PriceElectronic Access - Single User License$2950Electronic Access - Multi-User License$3750Custom Research License$7500

Report Price

To View Sample OR Purchase Report

Report Name: INDIA RESPIRATORY INHALERS MARKET

FORECAST & OPPORTUNITIES

FY2017 – FY2027

‹#›

13

About Us & Disclaimer

TechSci Research is a global market research and consulting company with offices in the US, UK and Australia. TechSci Research provides market research reports in number of areas to organizations. The company uses innovative business Modes that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting Modes use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ Mode of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.

Related Reports

Global 3D Mobile C-Arm Market By Application (Orthopedics, Trauma, Cardiovascular, Urology, Gastroenterology, Neurology, Others) By End Users (Hospitals, Specialty Clinics, Ambulatory Surgical Clinics) By Region, Competition Forecast & Opportunities, 2026.

India Remdesivir Market By Application (Ebola, SARS-COV, MERS-COV, COVID-19) By Route of Administration (Inhalation v/s Intravenous) By Dosage Form (Frozen Solution, Lypholized Solution) By Patient Age (Pediatric (12 years or older), Adult, Geriatric) By Distribution Channel (Hospitals, Clinics, Drug Stores/Pharmacies) By Region, Competition Forecast & Opportunities, FY2027.

The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.

TechSci Research – North America

708 Third Avenue, Manhattan,

New York, United States

Tel: +1- 646- 360- 1656

Email: sales@techsciresearch.com www.techsciresearch.com

Disclaimer

TechSci Research – Europe

54, Old brook, Bretton,

Peterborough,

United Kingdom

Email: sales@techsciresearch.com www.techsciresearch.com

TechSci Research – Asia-Pacific

B – 44, Sector – 57, Noida, National Capital Region, U.P. - Australia

Tel: +91-120-4523900

Email: sales@techsciresearch.com www.techsciresearch.com

14